The biology, pathophysiology and control of eicosanoids in inflammation
Tóm tắt
Higgins, A.J. The biology, pathophysiology and control of eicosanoids in inflammation.
The involvement in inflammatory conditions of those cyclo‐oxygenase and lipoxygenase derivatives of arachidonic acid (5, 8, 11, 14‐eicosatetraenoic acid), which are known as the eicosanoids, is reviewed iti the light of recent studies. Although it is now generally recognized that cyclo‐oxygenase products are fundamental to the inflammatory process as chemical mediators, and that inhibition of the cyclo‐oxygenase enzyme pathway explains the mode of action of most non‐steroidal anti‐inflammatory drugs (NSAIDs) commonly prescribed in veterinary practice, evidence for the involvement of lipoxygenase products of arachidonate metabolism in inflammation is increasing. The leukotrienes (LTs) are 5‐lipoxygenase‐derived eicosanoids which have been shown to be leucotactic and involved in anaphylactic and hypersensitivity reactions. Leucocytes, drawn to sites of injury by chemotaxis, themselves liberate pro‐inflammatory eicosanoids which perpetuate the response and may aggravate the clinical condition. At therapeutic dose rates, most NSAIDs have no effect on the biosynthesis of LTs, whereas corticosteroids, by inhibiting the release of arachidonic acid, may prevent the formation of both cyclo‐oxygenase and lipoxygenase products. However, because of the undesirable side‐effects of steroids, the clinical use of these agents in treating inflammatory conditions is sometimes limited. Novel non‐steroid inhibitors of cyclo‐oxygenase and lipoxygenase enzyme pathways could offer more effective and safer control of inflammation in animals.
Từ khóa
Tài liệu tham khảo
Anderson F.L., 1975, Prostaglandins F and E levels during endotoxin‐induced pulmonary hypertension in calves, American Journal of Physiology, 228, 1479, 10.1152/ajplegacy.1975.228.5.1479
Bakhle Y.S., 1983, Synthesis and catabolism of cyclo‐oxygenase products, British Medical Bulletin, 39, 214, 10.1093/oxfordjournals.bmb.a071821
Bhattacherjee P., 1981, Chemotactic activity of arachidonic acid lipoxygenase products in the rabbit eye, British Journal of Pharmacology, 73, 254
Borgeat P., 1976, Transformation of arachidonic acid and homo‐γ‐linolenic acid by rabbit polymorphonuclear leukocytes. Monohydroxy acids from novel lipoxygenases, Jounial of Biological Chemistry, 251, 7816, 10.1016/S0021-9258(19)57008-9
Bottoms G.D., 1981, Endotoxin‐induced hemodynamic changes in ponies: effects of flunixin meglumine, American Journal of Veterinary Research, 42, 1514
Bottoms G.D., 1982, Thromboxane, prostaglandin I2 (epoprostenol), and the hemodynamic changes in equine endotoxin shock, American Journal of Veterinary Research, 43, 999
Bult H., 1980, Advances in Prostaglandin and Thromboxane Research, 839
Chand N., 1977, Nonsteroidal antiinflammatory drugs: a review. New applications in hypersensitivity reactions of cattle and horses, Canadian Journal of Comparative Medicine, 41, 233
Eyre P., 1976, Preliminary studies of pharmacological antagonism of anaphylaxis in the horse, Canadian Journal of Comparative Medicine, 40, 149
Faull G.L., 1976, Clinical trials with orgo‐lein, Journal of the South African Veterinary Association, 47, 39
Ferreira S.H., 1974, The concomitant release of brady‐ktnin and prostaglandin in the inflammatory response to carrageenin, British Journal of Pharmacology, 52, 108P
Ferreira S.H., 1971, Indomethacin and aspirin abolish prostaglandin release from the spleen, Nature (Lond.), 231, 237, 10.1038/newbio231237a0
Fletcher J.R., 1980, The effects of prostacyclin (PGI3) on endotoxin shock and endotoxin‐induced platelet aggregation in dogs, Circulatory Sliock, 7, 299
Fletcher J.R., 1981, Thromboxane, prostacyclin and hemodynamic events in primate endotoxin shock, Advances in Shock Research, 5, 143
Frolich J.C., 1980, Aav‐auces in Prostaglandin and Thromboxane Research, 745
Gabel A.A., 1977, Phenylbutazone in horses: a review, Journal of Equine Medicine and Surgery, 1, 221
Goetzl E.J., 1980, The human PMN leukocyte chemotactic activity of complex hydroxy‐eicosatelraenoic acids (HETEs), Journal of Immunology, 125, 1789, 10.4049/jimmunol.125.4.1789
Gould S.R., 1976, Assay of prostaglandin‐like. substances in faeces and their measurement in ulcerative colitis, Lancet, 489
Greaves M.W., 1971, Recovery of prostaglandins in human cutaneous inflammation, British Medical Journal, 258, 10.1136/bmj.2.5756.258
Hamberg M., 1971, On the metabolism of Prostaglandins E1 and E2, in man, Journal of Biological Chemistry, 246, 6713, 10.1016/S0021-9258(19)45905-X
Herbaczynska‐Cedro K., 1974, Abstracts of tlie Ilnd Congress of the Hungarian Pharmacological Society, 19
Herman A.G., 1975, Release of prostaglandins and incapacitation after injection of endotoxin in the knee joint of the dog, British Journal of Pharmacology, 53, 465P
Higgins A.J., 1983, Phenylbutazone inhibition of prostaglandin E2 production in equine acute inflammatory exudate, Veterinary Record, 113, 622
Higgins A.J., 1984, Influence of phenylbutazone on eicosanoid levels in equine inflammatory exudate, Cornell Veterinarian, 74, 198
Higgins A.J., 1985, Flunixin meglumine: quantitative determination in and effects on composition of equine inllammatory exudate, British Veterinary Journal
Higgins A.J., 1984, A tissue‐cage model for the collection of inflammatory exudate in ponies, Research in Veterinary Science, 36, 284, 10.1016/S0034-5288(18)31948-9
Higgs G.A., 1982, Leukotrienes and Other Lipoxygenase Products, 331
Higgs G.A., 1978, 7th Inter‐nxitional Congress of Plmrmacology, 334
Higgs G.A., 1980, The mode of action of anti‐inflammatory drugs which prevent the peroxidation of arachidonic acid, Clinics in Rheumatic Diseases, 6, 675, 10.1016/S0307-742X(21)00323-4
Kauffman G.L., 1978, Prostaglandin and cimetidine inhibit antral ulcers produced by parenteral salicylates, Gastroenterology, 74, 1049, 10.1016/0016-5085(78)93185-2
Klebanoff S.J., 1975, The Phagocytic Cell in Host Resistance, 45
Kimura S.J., 1961, The effect of corticosteroid hormones on experimental herpes simplex keratitis. A clinical, histopathologic and histochemical study, American Journal of Ophtlmlmology, 51, 945
Klickstein L.B., 1980, Unique products of the oxygenation of arachidonic acid in synovial fluid in rheumatoid arthritis and spondylarthritis, Arthritis and Rheumatism, 23, 704
Lees P., 1985, Clinical pharmacology and theraeutic use of non‐steroidal annate, Research in Veterinary Science, 37, 347
Leopold I.H., 1976, The steroid shield in ophthalmology, Transactions of the American Academy of Ophtlmlmology and Otolaryngology, 71, 273
Mielants H., 1979, Salicylate‐induced gastrointestinal bleeding: comparison between soluble buffered, enteric‐coated, and intravenous administration, Journal of Rheunmtology, 6, 210
Moncada S., 1977, Interaction between anti‐inflammnatory drugs and inflammatory mediators: a reference lo products ol arachi‐donic acid metabolism, Agents niul Actions, 3, 141
Salmon J.A., 1979, Hormones in Blood, 237
Saxena P.M., 1979, Prostaglandin‐like activity in the cerebrospinal fluid of febrile patients, Indian Journal of Medical Research, 70, 495
Snow D.H., 1983, Pharmacological Basis of Large Animal Medicine, 391
Tamanini C., 1980, Concentrazione delle proslaglandiue E1‐E2 nel liquido sinoviale di cavalli af f'eli da artropa‐tie, Clinica veterinuriu, 103, 544
Teale A.J., 1983, Pharmacological Basis oj Large Animal Medicine, 428
Tobin T., 1979, Pharmacology review: the nonsteroidal anti‐inflammatory drugs. I. Phenylbutazone, Journal of Equine Medicine and Surgery, 3, 253
Vane J.R., 1974, Prostaglandin Synthetase Inhibitors, 155
Vernimb G.D., 1977, Clinical studies on llunixin meglumine in the treatment of equine colic, Journal oj Equine /Medicine and Surgery, 1, 111
Willis A.L., 1969, Prostaglandins. Peptides and Amines, 31